Irbesartan API is a pharmaceutical-grade Angiotensin II Receptor Blocker (ARB) widely used for the treatment of hypertension (high blood pressure) and diabetic nephropathy in patients with type 2 diabetes. It selectively blocks the binding of angiotensin II to the AT1 receptor, resulting in vasodilation, reduced blood pressure, and decreased cardiovascular workload.
Irbesartan is commonly formulated into oral tablet formulations and is recognized for its long duration of action, favorable safety profile, and effectiveness in reducing the risk of cardiovascular and renal complications associated with hypertension.
Manufactured under WHO-GMP-certified facilities, our Irbesartan API is produced using advanced pharmaceutical manufacturing processes to ensure exceptional purity, stability, and batch-to-batch consistency. Every batch undergoes comprehensive analytical testing and is supplied with Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), Technical Data Sheet (TDS), and complete regulatory documentation.
Irbesartan API is used in oral pharmaceutical formulations for the treatment of hypertension and diabetic nephropathy associated with type 2 diabetes.
Irbesartan selectively blocks angiotensin II type 1 (AT1) receptors, preventing vasoconstriction and aldosterone release, thereby lowering blood pressure and protecting the kidneys.
Yes. We provide CoA, MSDS, Technical Data Sheet (TDS), Product Specifications, and complete regulatory documentation with every shipment.
Yes. We supply Irbesartan API in commercial quantities with worldwide export support and customized packaging.
Get Bulk Quote via WhatsApp